GG
Gofen & Glossberg Portfolio holdings
AUM
$3.89B
This Quarter Return
+3.19%
1 Year Return
-11.97%
3 Year Return
+36.42%
5 Year Return
+73.97%
10 Year Return
–
AUM
$2.63B
AUM Growth
+$2.63B
(+3.1%)
Cap. Flow
+$6.65M
Cap. Flow
% of AUM
0.25%
Top 10 Holdings %
Top 10 Hldgs %
23.53%
Holding
504
New
17
Increased
138
Reduced
153
Closed
30
Top Buys
| 1 |
Johnson Controls International
JCI
|
$3.79M |
| 2 |
Becton Dickinson
BDX
|
$2.92M |
| 3 |
AGN
Allergan plc
AGN
|
$2.47M |
| 4 |
Core Laboratories
CLB
|
$2.2M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
$1.91M |
Top Sells
| 1 |
Newell Brands
NWL
|
$4.94M |
| 2 |
Target
TGT
|
$2.55M |
| 3 |
IBM
IBM
|
$1.64M |
| 4 |
National Grid
NGG
|
$1.44M |
| 5 |
Gilead Sciences
GILD
|
$954K |
Sector Composition
| 1 | Healthcare | 15.92% |
| 2 | Financials | 13.2% |
| 3 | Industrials | 11.82% |
| 4 | Technology | 11.08% |
| 5 | Consumer Staples | 10.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Coca-Cola
KO
$297B
| $24.1M | 0.92% | 537,676 -12,857 | -2% | -$577K |
|
27
Merck
MRK
$210B
| $24M | 0.91% | 373,728 +5,189 | +1% | +$333K |
|
28
3M
MMM
$82.8B
| $23.6M | 0.9% | 113,411 -449 | -0.4% | -$93.5K |
|
29
ASML
ASML
$292B
| $23.1M | 0.88% | 177,346 -276 | -0.2% | -$36K |
|
30
Abbott
ABT
$231B
| $23.1M | 0.88% | 474,899 +787 | +0.2% | +$38.3K |
|
31
Mondelez International
MDLZ
$79.5B
| $22.7M | 0.86% | 526,180 +11,982 | +2% | +$518K |
|
32
Meta Platforms (Facebook)
META
$1.86T
| $22.6M | 0.86% | 149,460 +5,079 | +4% | +$767K |
|
33
Novartis
NVS
$245B
| $21.6M | 0.82% | 258,768 -3,485 | -1% | -$291K |
|
34
MetLife
MET
$54.1B
| $21.2M | 0.81% | 385,527 +5,515 | +1% | +$303K |
|
35
Nike
NKE
$114B
| $20.6M | 0.78% | 349,526 +30,957 | +10% | +$1.83M |
|
36
Wells Fargo
WFC
$263B
| $20.6M | 0.78% | 371,072 -816 | -0.2% | -$45.2K |
|
|
DD
37
DELISTED
Du Pont De Nemours E I
DD
| $20.2M | 0.77% | 250,125 -1,302 | -0.5% | -$105K |
|
|
AGN
38
DELISTED
Allergan plc
AGN
| $20.2M | 0.77% | 83,035 +10,159 | +14% | +$2.47M |
|
39
Berkshire Hathaway Class B
BRK.B
$1.09T
| $19.9M | 0.76% | 117,452 -948 | -0.8% | -$161K |
|
40
Verizon
VZ
$186B
| $19.2M | 0.73% | 429,744 -13,070 | -3% | -$584K |
|
41
Mastercard
MA
$538B
| $19.1M | 0.72% | 157,023 +1,081 | +0.7% | +$131K |
|
42
Alphabet (Google) Class A
GOOGL
$2.57T
| $19M | 0.72% | 20,419 +4 | +0% | +$3.72K |
|
|
UN
43
DELISTED
Unilever NV New York Registry Shares
UN
| $18.9M | 0.72% | 341,212 -2,735 | -0.8% | -$151K |
|
44
Philip Morris
PM
$260B
| $18.6M | 0.71% | 158,230 -6,026 | -4% | -$708K |
|
|
45
Gilead Sciences
GILD
$140B
| $18.3M | 0.7% | 258,796 -13,477 | -5% | -$954K |
|
46
Zoetis
ZTS
$69.3B
| $18.1M | 0.69% | 289,349 -773 | -0.3% | -$48.2K |
|
47
Citigroup
C
$178B
| $18M | 0.68% | 268,842 +2,417 | +0.9% | +$162K |
|
48
NXP Semiconductors
NXPI
$59.2B
| $17.2M | 0.65% | 156,708 -500 | -0.3% | -$54.7K |
|
49
Danaher
DHR
$147B
| $16.8M | 0.64% | 198,688 +4,195 | +2% | +$354K |
|
50
Broadcom
AVGO
$1.4T
| $16.7M | 0.63% | 71,504 +1,820 | +3% | +$424K |
|